Your browser doesn't support javascript.
loading
[Typhoid and paratyphoid fever]. / Typhus abdominalis und Paratyphus.
Trawinski, Henning; Wendt, Sebastian; Lippmann, Norman; Heinitz, Sascha; von Braun, Amrei; Lübbert, Christoph.
Afiliación
  • Trawinski H; Bereich Infektions- und Tropenmedizin, Klinik und Poliklinik für Gastroenterologie, Hepatologie, Infektiologie, Pneumologie, Universitätsklinikum Leipzig.
  • Wendt S; Interdisziplinäres Zentrum für Infektionsmedizin (ZINF), Universitätsklinikum Leipzig.
  • Lippmann N; Bereich Infektions- und Tropenmedizin, Klinik und Poliklinik für Gastroenterologie, Hepatologie, Infektiologie, Pneumologie, Universitätsklinikum Leipzig.
  • Heinitz S; Interdisziplinäres Zentrum für Infektionsmedizin (ZINF), Universitätsklinikum Leipzig.
  • von Braun A; Institut für Medizinische Mikrobiologie und Infektionsepidemiologie, Universitätsklinikum Leipzig.
  • Lübbert C; Institut für Medizinische Mikrobiologie und Infektionsepidemiologie, Universitätsklinikum Leipzig.
Z Gastroenterol ; 58(2): 160-170, 2020 Feb.
Article en De | MEDLINE | ID: mdl-32050286
ABSTRACT
Typhoid fever and paratyphoid fever are systemic infectious diseases of global significance caused by Salmonella enterica subspecies enterica Serovar Typhi (short name Salmonella Typhi) or Serovar Paratyphi (short name Salmonella Paratyphi). The course of these fecal-orally transmitted diseases is mainly characterized by a high fever. Left untreated, the course of typhoid fever can be severe and lethal. The infection is almost always acquired outside of Europe (mainly in India) and is notifiable in Germany, Austria and Switzerland. Paratyphoid is an attenuated disease of typhoid fever caused by Salmonella Paratyphi. Available vaccines only protect against Salmonella Typhi. Antibiotic resistance reflects the situation in endemic countries and shows a worrying increase of multi-drug resistant isolates. Currently, third-generation cephalosporins such as ceftriaxone are recommended as first-line therapy; if sensitive to quinolones, fluoroquinolones such as ciprofloxacin may continue to be administered. Crucial preventive measures for travelers to endemic regions include consistent water and food hygiene as well as vaccination, whereby only protection rates of 50-70 % are achieved by currently available vaccines. In the light of increasing multi-drug resistance, a more effective conjugate vaccine against Salmonella Typhi with cross-reactivity against Salmonella Paratyphi is needed more than ever.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Salmonella paratyphi A / Salmonella typhi / Fiebre Tifoidea / Fiebre Paratifoidea / Vacunas Conjugadas / Antibacterianos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: De Revista: Z Gastroenterol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Salmonella paratyphi A / Salmonella typhi / Fiebre Tifoidea / Fiebre Paratifoidea / Vacunas Conjugadas / Antibacterianos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: De Revista: Z Gastroenterol Año: 2020 Tipo del documento: Article